CN101917998A - 在常规治疗后尿道狭窄复发的预防 - Google Patents
在常规治疗后尿道狭窄复发的预防 Download PDFInfo
- Publication number
- CN101917998A CN101917998A CN2008801131027A CN200880113102A CN101917998A CN 101917998 A CN101917998 A CN 101917998A CN 2008801131027 A CN2008801131027 A CN 2008801131027A CN 200880113102 A CN200880113102 A CN 200880113102A CN 101917998 A CN101917998 A CN 101917998A
- Authority
- CN
- China
- Prior art keywords
- urethral
- compositions
- recurrence
- halofuginone
- urethral stricture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
Abstract
Description
变量 | 卤夫酮 | 对照组 | p值 |
兔的数目 | 10 | 10 | |
尿道狭窄的数目 | 10 | 2 | <0.001 |
变量 | 卤夫酮治疗组 | 对照组 | p值 |
兔的数目 | 18 | 19 | |
凝固后狭窄的外观 | |||
平均长度(mm) | 11.4 | 11.6 | 0.85 |
腔缩小的平均值(%) | 88.3 | 88.4 | 0.89 |
尿道切开术后复发的狭窄 | |||
数目/总数目(%) | 5/18(27) | 14/19(73) | 0.005 |
平均长度(mm) | 7.2 | 11.4 | |
腔缩小的平均值(%) | 92 | 82.9 | |
根据组织学纤维化程度而确定的数目 | |||
严重 | 4 | 12 |
中等至严重 | 1 | 2 | |
轻度或没有 | 13 | 5 |
Claims (6)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR07/07387 | 2007-10-23 | ||
FR0707387A FR2922451A1 (fr) | 2007-10-23 | 2007-10-23 | Traitement des retrecissements de l'uretre |
PCT/IB2008/003375 WO2009053842A2 (fr) | 2007-10-23 | 2008-10-23 | Prévention des récidives du rétrécissement de l'urètre après un traitement classique |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101917998A true CN101917998A (zh) | 2010-12-15 |
Family
ID=39345287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008801131027A Pending CN101917998A (zh) | 2007-10-23 | 2008-10-23 | 在常规治疗后尿道狭窄复发的预防 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20100305144A1 (zh) |
EP (1) | EP2240180A2 (zh) |
CN (1) | CN101917998A (zh) |
AU (1) | AU2008315685A1 (zh) |
FR (1) | FR2922451A1 (zh) |
RU (2) | RU2010120687A (zh) |
WO (1) | WO2009053842A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111107890A (zh) * | 2017-10-06 | 2020-05-05 | Gn股份有限公司 | 尿道狭窄治疗剂和尿道狭窄治疗方法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10335573B2 (en) | 2015-12-02 | 2019-07-02 | Cook Medical Technologies Llc | Intraperitoneal chemotherapy medical devices, kits, and methods |
RU2723994C1 (ru) * | 2019-10-14 | 2020-06-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургская государственная академия ветеринарной медицины ФГБОУ ВО СПбГАВМ | Способ профилактики и лечения стриктур уретры и зарастания урестостомы у кошек |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3320124A (en) * | 1964-07-20 | 1967-05-16 | American Cyanamid Co | Method for treating coccidiosis with quinazolinones |
CA2113229C (en) * | 1994-01-11 | 1999-04-20 | Mark Pines | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof |
US20050163818A1 (en) * | 1996-11-05 | 2005-07-28 | Hsing-Wen Sung | Drug-eluting device chemically treated with genipin |
EP1210086B1 (en) * | 1999-09-09 | 2006-12-06 | Hadasit Medical Research Services & Development Co., Ltd. | Use of halofuginone for treating urethral stricture |
-
2007
- 2007-10-23 FR FR0707387A patent/FR2922451A1/fr active Pending
-
2008
- 2008-10-23 WO PCT/IB2008/003375 patent/WO2009053842A2/fr active Application Filing
- 2008-10-23 CN CN2008801131027A patent/CN101917998A/zh active Pending
- 2008-10-23 RU RU2010120687/15A patent/RU2010120687A/ru unknown
- 2008-10-23 EP EP08841527A patent/EP2240180A2/fr not_active Withdrawn
- 2008-10-23 US US12/739,324 patent/US20100305144A1/en not_active Abandoned
- 2008-10-23 AU AU2008315685A patent/AU2008315685A1/en not_active Abandoned
-
2014
- 2014-02-13 RU RU2014105453/15A patent/RU2014105453A/ru not_active Application Discontinuation
- 2014-03-24 US US14/222,941 patent/US20140288102A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
MEHDI JAIDANE ET AL.: "The use of halofuginone in limiting urethral stricture formation and recurrence:an experimental study in rabbits", 《THE JOURNAL OF UROLOGY》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111107890A (zh) * | 2017-10-06 | 2020-05-05 | Gn股份有限公司 | 尿道狭窄治疗剂和尿道狭窄治疗方法 |
Also Published As
Publication number | Publication date |
---|---|
RU2010120687A (ru) | 2011-11-27 |
EP2240180A2 (fr) | 2010-10-20 |
US20100305144A1 (en) | 2010-12-02 |
AU2008315685A1 (en) | 2009-04-30 |
RU2014105453A (ru) | 2015-08-20 |
FR2922451A1 (fr) | 2009-04-24 |
WO2009053842A3 (fr) | 2009-11-05 |
US20140288102A1 (en) | 2014-09-25 |
WO2009053842A2 (fr) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PRESTON et al. | Cutaneous neurofibromatosis (von Recklinghausen's disease): clinical manifestations and incidence of sarcoma in sixty-one male patients | |
CN102743380B (zh) | 用于治疗或预防酒渣鼻的化合物、制剂和方法 | |
Tate et al. | Laparoscopic versus open appendicectomy: prospective randomised trial | |
Scheinin et al. | Effect of intraperitoneal bupivacaine on pain after laparoscopic cholecystectomy | |
Raysi Dehcordi et al. | Laparoscopy-assisted ventriculoperitoneal shunt surgery: personal experience and review of the literature | |
Balossier et al. | Endoscopic versus stereotactic procedure for pineal tumour biopsies: comparative review of the literature and learning from a 25-year experience | |
Stevens et al. | Clinical and financial aspects of cholecystectomy: laparoscopic versus open technique | |
CN1298309A (zh) | 治疗肛门区疼痛的方法及其组合物 | |
DUNN et al. | Laparoscopic cyst marsupialization in patients with autosomal dominant polycystic kidney disease | |
CN101917998A (zh) | 在常规治疗后尿道狭窄复发的预防 | |
EP1728508B1 (en) | Medicine for prevention or treatment of frequent urination or urinary incontinence | |
HU215959B (hu) | Eljárás 5-metil-izoxazol-4-karbonsav-anilideket vagy 2-hidroxi-etilidén ciano-ecetsav-anilideket tartalmazó, szembetegségek kezelésére helyileg alkalmazható gyógyszerkészítmények előállítására | |
Foo et al. | Ambulatory anorectal surgery-is it feasible locally? | |
CA2448449A1 (en) | Treatment of renal fibrosis | |
KR20200026118A (ko) | 헬리코박터 파일로리 제균용 조성물 | |
AU2002309211A1 (en) | Treatment of renal fibrosis | |
CN117715661A (zh) | 用于nirf成像的普地沙铵 | |
Sethi et al. | Endoscopic pituitary surgery: a minimally invasive technique | |
JP2003522121A (ja) | 多発性硬化症の処置のためのリルゾールの使用 | |
Kilicarslan et al. | Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin | |
EP1210086B1 (en) | Use of halofuginone for treating urethral stricture | |
Poletajew et al. | Anaesthesia of the posterior urethra and pain reduction during cystoscopy–a randomized controlled trial | |
Wongsirisuwan | The Long-Term Patency of the Internal Jugular Vein and the Common Facial Vein as Entrance Sites for Venous Access in Ventriculoatrial Shunts: A Comparative Analysis from a Single-Center Study | |
Guazzoni et al. | Prostatic Spiral versus Prostatic Urolume Wallstent for Urinary Retention due to Benign Prostatic Hyperplasia | |
Hood et al. | A survey of infections in stereotactic surgery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110919 Address after: Lausanne Applicant after: Wen Gan trading Limited by Share Ltd Address before: The British Virgin Islands of Tortola Applicant before: Windgan Trading Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: ALAIN LEBET Free format text: FORMER OWNER: WINDGAN TRADING LTD. Effective date: 20130924 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130924 Address after: Lausanne Applicant after: Lebet Alain Address before: Lausanne Applicant before: Wen Gan trading Limited by Share Ltd |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20101215 |